Delaware
Delaware
In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.
In Your State
Economic Impact In Your State: Delaware
Economic Impact
$2.8B
Total output supported by biopharmaceutical sector
$164.5M
Tax Revenue Generated
8,597
Total Jobs
4,267
Direct Jobs
68
Total Clinical Trials
$7.3 million
Invested in Clinical Trials
770
Total Economic Impact of Clinical Trial Investments
$18.1 million
Invested in Clinical Trials
Programs and Initiatives in Your State: Delaware
State programs and initiatives to promote biopharmaceutical industry development
- Accelerating Innovation, Commercialization & Entrepreneurial Development
- Building Advanced Manufacturing
- Building Research Capacity and/or R&D Infrastructure
- Economic Innovation Incentives
- STEM Education & Workforce Development
- Targeted Strategies
- Venture Financing
Programs and Initiatives
19
Patents per 1,000 people in Science & Engineering
Percentage of Workforce Employed in High-Tech Jobs